U.S. Marine and Shipping Stock News

Earlier this month, Moderna announced it had dosed the first U.S. participant in a Phase 1 trial of mRNA-4200, an mRNA-based, tumor-targeted cancer antigen therapy being tested with checkpoint inhibitor treatment in adults with advanced solid tumors under its collaboration with Immatics. This early-stage oncology milestone underscores Moderna’s effort to extend its mRNA platform beyond infectious diseases into cancer, adding a new dimension to how investors may think about the company’s...

CoreCivic (CXW) has moved to redeem all remaining 4.750% senior notes due 2027, a US$238.5m balance, effective August 12, 2026, using cash on hand, drawing attention to the company’s capital structure. See our latest analysis for CoreCivic. CoreCivic’s decision to fully redeem its 2027 notes comes after a strong run in the stock, with a 30 day share price return of 8.8% and a 90 day gain of 49.9%, while the 3 year total shareholder return of 233.2% points to powerful longer term momentum. If...

Peoples Bancorp stock has delivered a 77.3% return over the past 5 years. At a last close of US$39.39, the Excess Returns intrinsic value estimate still points to meaningful upside, while the market multiples suggest the shares are priced roughly in line with peers. Over 5 years, a 77.3% total return suggests the market has already repriced Peoples Bancorp materially higher, so the easy gains may be behind it. Future profitability and loan growth can support the current valuation, but...

Prologis (PLD) kicked off its Q2 2026 update with revenue of about US$2.4 billion and basic EPS of roughly US$1.11 for the quarter, alongside trailing twelve month earnings growth of 22.1% and a net margin of 43.8%. Over the past six quarters, the company has seen revenue move from about US$2.21 billion in Q1 2025 to roughly US$2.43 billion in Q2 2026, with trailing twelve month revenue reaching about US$9.6 billion and basic EPS of around US$4.52. For investors, the combination of higher...

Earlier this week, TJX Companies drew attention as analysts projected higher upcoming earnings per share and revenue versus the prior year, alongside a Zacks Rank of #2, reflecting generally favorable sentiment toward the off‑price retailer. What stands out is that this optimism around TJX’s earnings outlook has held firm even while broader equity markets have been under pressure, hinting at perceived resilience in its value-focused retail model. We’ll now examine how this upbeat analyst...

Diodes (DIOD) has drawn investor attention after recent trading moves, with the stock down about 20% over the past month and roughly 8% over the past 3 months, despite positive annual revenue growth. See our latest analysis for Diodes. Over a longer stretch, Diodes shows strong upward momentum, with a year to date share price return of 69.20%, even though recent weakness includes a 7 day share price decline of 9.71% and a 1 year total shareholder return of 58.28%. If recent volatility has you...

Lumen Technologies previously announced that the New York Yankees selected it to power the network connecting Yankee Stadium and the team’s Tampa, Florida facilities, including a new 200-mph wind-rated data center linked by two diverse 100-gigabit fiber paths with automatic failover. This partnership gives Lumen a high-profile showcase for its Network-as-a-Service model, highlighting on-demand scalability for everything from fan Wi-Fi to media workloads across an AI-ready...

Artificial intelligence in healthcare is attracting fresh attention as investors weigh inflation trends, shifting interest rate expectations, and volatile energy costs across major economies. While higher yields and mixed growth signals are reshaping risk appetite, AI Healthcare Stocks sit at the intersection of cost pressure and the search for better outcomes, using data to support diagnostics, treatment decisions, and efficiency. The Transformative AI Healthcare Stocks screener focuses on...

The planned rebuild of the Kirkuk to Mediterranean oil pipeline could reshuffle how crude moves out of the Middle East, and that matters for your portfolio. A more secure export route that reduces dependence on the Strait of Hormuz may ease oil price risk, and that can change the cost base for energy intensive sectors. This article looks at how that news links back to our Energy Intensive Industries screener and what it could mean for stock selection. You will see 3 stocks exposed to this...

Powell Industries has delivered an exceptionally strong long term share price return over the past five years, yet its current valuation checks lean expensive rather than cheap. Powell Industries has returned about 25x over the last five years, which puts extra focus on whether the current share price already reflects investors' expectations. Growing interest in power infrastructure for data centers can support elevated expectations for future earnings, but recent pressure on the share price...

With softer U.S. inflation, shifting expectations for Federal Reserve rate moves, a weaker dollar and firmer oil prices, many investors are taking a fresh look at U.S. dividend stocks as potential sources of steady income and relative stability. This article focuses on large companies in traditionally resilient areas such as utilities, consumer staples, healthcare and industrials. All are drawn from a U.S. Dividend Stocks screener built around these macro shifts. You will see 3 stocks that...

Construction Partners, Inc. previously announced it would release its fiscal 2026 third-quarter results on August 7, 2026, accompanied by an investor conference call that morning to discuss its performance. This update has drawn attention to the company’s improving free cash flow margins and acquisition-driven expansion, which are shaping how investors view its long-term fundamentals. Now we’ll examine how growing anticipation around the upcoming earnings release and improving free cash...

Barclays downgrade and 52 week low put LegalZoom.com (LZ) under the microscope LegalZoom.com (LZ) is back in focus after a Barclays downgrade and a slide to a fresh 52 week low, as investors reassess its growth outlook and its reaction to emerging AI tools. See our latest analysis for LegalZoom.com. The Barclays downgrade comes after a sharp rebound in LegalZoom.com’s recent share price performance, with a 30 day share price return of 38.6% and a 90 day gain of 18.95%. However, longer term...

Recent Performance Context for V.F Stock Without a specific news catalyst, V.F (VFC) is attracting attention as investors weigh its recent share performance against reported annual revenue of US$9.6b and net income of US$254.9m. The stock is up in the past month but down over the past 3 months, with a contrasting 1 year total return gain and a weaker multi year track record. This mixed picture is shaping how investors assess V.F today. See our latest analysis for V.F. V.F’s recent 1 day share...

Ionis Pharmaceuticals (NasdaqGS:IONS) has dosed the first participant in the Phase 1-2 ASCEND trial of ION337 for Dravet syndrome. The study marks the first clinical evaluation of ION337, a next generation RNA targeted therapy candidate. ION337 has FDA Fast Track designation for Dravet syndrome, a rare seizure disorder with no approved disease modifying treatments. For investors following Ionis Pharmaceuticals, this new trial adds a fresh data point to the company’s rare disease portfolio...

Texas Capital Bancshares has delivered a 68.2% return over the past five years, yet the current valuation picture is mixed, with the Excess Returns intrinsic value estimate indicating the stock may trade below its estimated worth while market multiples sit closer to about right. A 68.2% return over five years points to a stock that has already rewarded patient shareholders, so the question is how much valuation upside may still be on the table. The appointment of Mo Jamous as Chief Digital...

The Cyclospora parasite outbreak linked to shredded iceberg lettuce at Taco Bell has pushed Yum! Brands (YUM) into the spotlight, with investors weighing food safety concerns alongside the company’s upcoming second quarter results on July 30. See our latest analysis for Yum! Brands. Recent trading reflects those concerns, with Yum! Brands’ share price down 2.75% over the past day and 9.55% over the past week. Its 1 year total shareholder return of 1.21% and 5 year total shareholder return of...

Mattel stock has had a tough run over the past three years, yet its current valuation checks lean cheap, which sets up a clear tension between weak long term returns and a market price that screens as potentially modestly undervalued. Mattel has declined 32.5% over the past three years, which means today’s valuation is being judged against a share price that has already come down meaningfully. On the upside, UBS has highlighted Mattel’s broad brand portfolio as a source of brand equity that...

Moody's (MCO) is back in focus after Intapp, Inc. expanded its collaboration to plug Moody's financial risk data directly into Intapp Celeste, an agentic AI platform used across legal, private capital, and accounting firms. See our latest analysis for Moody's. Against the backdrop of this Intapp collaboration, Moody's share price is trading at US$510.86, with a 30 day share price return of 11.98% and a 90 day share price return of 12.19%, while the 3 year total shareholder return of 46.33%...

LyondellBasell Industries (LYB) is in focus after unveiling a flexible packaging solution for Mondelez's Marabou chocolate bars, using ISCC PLUS-certified CirculenRevive polymers with 100% attributed recycled content. See our latest analysis for LyondellBasell Industries. LyondellBasell Industries shares recently closed at US$59.17, with a 1 day share price return of 2.37% and a 7 day return of 5.00%. Over the past 30 and 90 days, the share price returns declined 4.27% and 10.71%...

Cooling U.S. inflation, softer energy costs and a less aggressive Federal Reserve have shifted the focus back to dependable income stocks that can still grow their payouts. With annual inflation at 3.5% and core inflation at 2.6%, dividend growth stocks look interesting as potential anchors in portfolios that seek stability alongside income potential. This article walks through 3 dividend growers from our Dividend Growth Stocks screener that appear well positioned, based on their exposure to...

The recent move in Arcutis Biotherapeutics (ARQT) comes after the FDA accepted a supplemental application for ZORYVE cream 0.05%, which could extend its use to infants with mild to moderate atopic dermatitis. See our latest analysis for Arcutis Biotherapeutics. Against this backdrop, Arcutis Biotherapeutics’ recent 1-month share price return of 8.66% and 90-day share price return of 16.14% suggest improving momentum, while the year-to-date share price return has slightly declined 1.76%. Over...

Apollo Global Management (APO) has moved into the spotlight after easyJet backed its surprise takeover offer, valuing the airline at about £5.7b and setting up a bidding contest with rival suitor Castlelake. See our latest analysis for Apollo Global Management. Beyond the EasyJet bid, Apollo Global Management has been busy on the deal front. It recently closed the acquisitions of Emerald Holding and Questex and combined them into a single B2B events and media platform. This comes at a time...

Recent analyst coverage has pushed Cheesecake Factory (CAKE) into focus for growth oriented investors, highlighting favorable growth scores and a track record of positive earnings surprises ahead of its late July 2026 earnings report. See our latest analysis for Cheesecake Factory. The recent 36.84% 3 month share price return and 62.41% year to date share price return to about $85.77 suggest momentum has been building around Cheesecake Factory as investors react to its earnings track record...